Loop Capital Downgrades Weave Communications to Hold

Loop Capital analyst Mark Schappel downgrades Weave Communications (NYSE:WEAV) from Buy to Hold.

Loop Capital analyst Mark Schappel downgrades Weave Communications (NYSE:WEAV) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

Zai Lab Ltd Says National Medical Products Administration Approved Biologics License Application For Vyvgart For Treating Generalized Myasthenia Gravis

First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG patients treated with VYVGART were responders (n=44/65) on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale compared with 30% of patients treated with placebo (n=19/64) (p<0.0001) during the first treatment cycle in the Phase 3 ADAPT trial

ARGX